DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Carisbamate is an investigational drug.
There have been 14 clinical trials for Carisbamate. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2009.
The most common disease conditions in clinical trials are Epilepsy, Epilepsies, Partial, and Seizures. The leading clinical trial sponsors are SK Life Science, SK Life Science, Inc., and Baylor College of Medicine.
Recent Clinical Trials for Carisbamate
|Bioavailability and Food Effect Study of 3 Types of Carisbamate||PRA Health Sciences||Phase 1|
|Bioavailability and Food Effect Study of 3 Types of Carisbamate||SK Life Science, Inc.||Phase 1|
|Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome||SK Life Science, Inc.||Phase 1|